Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Jagsonpal Pharmaceuticals Limited
  6. News
  7. Summary
    JAGSNPHARM   INE048B01027

JAGSONPAL PHARMACEUTICALS LIMITED

(JAGSNPHARM)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020

02/12/2021 | 04:22am EDT

Jagsonpal Pharmaceuticals Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 576.391 million compared to INR 426.612 million a year ago. Net income was INR 54.303 million compared to INR 22.832 million a year ago. Basic earnings per share from continuing operations was INR 2.07 compared to INR 0.87 a year ago. For the nine months, total revenue was INR 1,468.419 million compared to INR 1,308.161 million a year ago. Net income was INR 119.594 million compared to INR 63.16 million a year ago. Basic earnings per share from continuing operations was INR 4.57 compared to INR 2.41 a year ago.


ę S&P Capital IQ 2021
All news about JAGSONPAL PHARMACEUTICALS LIMITED
09/22JAGSONPAL PHARMACEUTICALS LIMITED : Ex-dividend day for final dividend
FA
08/15Jagsonpal Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2022
CI
08/13Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended ..
CI
06/30Jagsonpal Pharmaceuticals Limited Recommends Dividend
CI
06/30Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended..
CI
02/12Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended ..
CI
2020Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended..
CI
2020Jagsonpal Pharmaceuticals Limited Approves to Declare Final Dividend for the Financial ..
CI
2020JAGSONPAL PHARMACEUTICALS LIMITED : Ex-dividend day for final dividend
FA
2020Jagsonpal Pharmaceuticals Limited Proposes Final Dividend for the Financial Year Ended ..
CI
More news
Financials
Sales 2021 1 879 M 25,5 M 25,5 M
Net income 2021 171 M 2,31 M 2,31 M
Net cash 2021 554 M 7,51 M 7,51 M
P/E ratio 2021 12,2x
Yield 2021 1,26%
Capitalization 3 968 M 53,8 M 53,8 M
EV / Sales 2020 0,08x
EV / Sales 2021 0,81x
Nbr of Employees -
Free-Float 24,9%
Chart JAGSONPAL PHARMACEUTICALS LIMITED
Duration : Period :
Jagsonpal Pharmaceuticals Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JAGSONPAL PHARMACEUTICALS LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Managers and Directors
Rajpal Singh Kochhar Chairman & Managing Director
Sanjiv Kumar Dudeja Chief Financial Officer
Nandita Singh Secretary & Compliance Officer
Bharat Sinh Independent Non-Executive Director
Ishpal Singh Ghai Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
JAGSONPAL PHARMACEUTICALS LIMITED111.67%54
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.20.05%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037